72 related articles for article (PubMed ID: 16764821)
1. Distinct gene expression signature in Btk-defective T1 B-cells.
Lindvall JM; Blomberg KE; Berglöf A; Smith CI
Biochem Biophys Res Commun; 2006 Jul; 346(2):461-9. PubMed ID: 16764821
[TBL] [Abstract][Full Text] [Related]
2. Early arrest in B cell development in transgenic mice that express the E41K Bruton's tyrosine kinase mutant under the control of the CD19 promoter region.
Maas A; Dingjan GM; Grosveld F; Hendriks RW
J Immunol; 1999 Jun; 162(11):6526-33. PubMed ID: 10352268
[TBL] [Abstract][Full Text] [Related]
3. Bruton's tyrosine kinase: cell biology, sequence conservation, mutation spectrum, siRNA modifications, and expression profiling.
Lindvall JM; Blomberg KE; Väliaho J; Vargas L; Heinonen JE; Berglöf A; Mohamed AJ; Nore BF; Vihinen M; Smith CI
Immunol Rev; 2005 Feb; 203():200-15. PubMed ID: 15661031
[TBL] [Abstract][Full Text] [Related]
4. Gene expression profile of B cells from Xid mice and Btk knockout mice.
Lindvall JM; Blomberg KE; Berglöf A; Yang Q; Smith CI; Islam TC
Eur J Immunol; 2004 Jul; 34(7):1981-91. PubMed ID: 15214046
[TBL] [Abstract][Full Text] [Related]
5. Bruton's tyrosine kinase is not essential for LPS-induced activation of human monocytes.
Pérez de Diego R; López-Granados E; Pozo M; Rodríguez C; Sabina P; Ferreira A; Fontan G; García-Rodríguez MC; Alemany S
J Allergy Clin Immunol; 2006 Jun; 117(6):1462-9. PubMed ID: 16751014
[TBL] [Abstract][Full Text] [Related]
6. The Bruton's tyrosine kinase gene is expressed throughout B cell differentiation, from early precursor B cell stages preceding immunoglobulin gene rearrangement up to mature B cell stages.
de Weers M; Verschuren MC; Kraakman ME; Mensink RG; Schuurman RK; van Dongen JJ; Hendriks RW
Eur J Immunol; 1993 Dec; 23(12):3109-14. PubMed ID: 8258324
[TBL] [Abstract][Full Text] [Related]
7. Bruton's tyrosine kinase expression and activity in X-linked agammaglobulinaemia (XLA): the use of protein analysis as a diagnostic indicator of XLA.
Gaspar HB; Lester T; Levinsky RJ; Kinnon C
Clin Exp Immunol; 1998 Feb; 111(2):334-8. PubMed ID: 9486400
[TBL] [Abstract][Full Text] [Related]
8. Inactivation of Btk by insertion of lacZ reveals defects in B cell development only past the pre-B cell stage.
Hendriks RW; de Bruijn MF; Maas A; Dingjan GM; Karis A; Grosveld F
EMBO J; 1996 Sep; 15(18):4862-72. PubMed ID: 8890160
[TBL] [Abstract][Full Text] [Related]
9. Severe B cell deficiency and disrupted splenic architecture in transgenic mice expressing the E41K mutated form of Bruton's tyrosine kinase.
Dingjan GM; Maas A; Nawijn MC; Smit L; Voerman JS; Grosveld F; Hendriks RW
EMBO J; 1998 Sep; 17(18):5309-20. PubMed ID: 9736610
[TBL] [Abstract][Full Text] [Related]
10. Defective Toll-like receptor 9-mediated cytokine production in B cells from Bruton's tyrosine kinase-deficient mice.
Hasan M; Lopez-Herrera G; Blomberg KE; Lindvall JM; Berglöf A; Smith CI; Vargas L
Immunology; 2008 Feb; 123(2):239-49. PubMed ID: 17725607
[TBL] [Abstract][Full Text] [Related]
11. Expression of Bruton's agammaglobulinemia tyrosine kinase gene, BTK, is selectively down-regulated in T lymphocytes and plasma cells.
Smith CI; Baskin B; Humire-Greiff P; Zhou JN; Olsson PG; Maniar HS; Kjellén P; Lambris JD; Christensson B; Hammarström L
J Immunol; 1994 Jan; 152(2):557-65. PubMed ID: 8283037
[TBL] [Abstract][Full Text] [Related]
12. Mutational analysis of the SH2-kinase linker region of Bruton's tyrosine kinase defines alternative modes of regulation for cytoplasmic tyrosine kinase families.
Guo S; Wahl MI; Witte ON
Int Immunol; 2006 Jan; 18(1):79-87. PubMed ID: 16291652
[TBL] [Abstract][Full Text] [Related]
13. xid mice reveal the interplay of homeostasis and Bruton's tyrosine kinase-mediated selection at multiple stages of B cell development.
Cancro MP; Sah AP; Levy SL; Allman DM; Schmidt MR; Woodland RT
Int Immunol; 2001 Dec; 13(12):1501-14. PubMed ID: 11717191
[TBL] [Abstract][Full Text] [Related]
14. Characterization of Bruton's tyrosine kinase mutations in Mexican patients with X-linked agammaglobulinemia.
Lopez-Herrera G; Berron-Ruiz L; Mogica-Martinez D; Espinosa-Rosales F; Santos-Argumedo L
Mol Immunol; 2008 Feb; 45(4):1094-8. PubMed ID: 17765309
[TBL] [Abstract][Full Text] [Related]
15. Cellular maturation defects in Bruton's tyrosine kinase-deficient immature B cells are amplified by premature B cell receptor expression and reduced by receptor editing.
Middendorp S; Hendriks RW
J Immunol; 2004 Feb; 172(3):1371-9. PubMed ID: 14734712
[TBL] [Abstract][Full Text] [Related]
16. BTK mutations in patients with X-linked agammaglobulinemia: lack of correlation between presence of peripheral B lymphocytes and specific mutations.
Tao L; Boyd M; Gonye G; Malone B; Schwaber J
Hum Mutat; 2000 Dec; 16(6):528-9. PubMed ID: 11102984
[TBL] [Abstract][Full Text] [Related]
17. Altered splenic B cell subset development in mice lacking phosphoinositide 3-kinase p85alpha.
Donahue AC; Hess KL; Ng KL; Fruman DA
Int Immunol; 2004 Dec; 16(12):1789-98. PubMed ID: 15520044
[TBL] [Abstract][Full Text] [Related]
18. Bruton's tyrosine kinase (Btk): function, regulation, and transformation with special emphasis on the PH domain.
Mohamed AJ; Yu L; Bäckesjö CM; Vargas L; Faryal R; Aints A; Christensson B; Berglöf A; Vihinen M; Nore BF; Smith CI
Immunol Rev; 2009 Mar; 228(1):58-73. PubMed ID: 19290921
[TBL] [Abstract][Full Text] [Related]
19. Genomic organization of mouse and human Bruton's agammaglobulinemia tyrosine kinase (Btk) loci.
Sideras P; Müller S; Shiels H; Jin H; Khan WN; Nilsson L; Parkinson E; Thomas JD; Brandén L; Larsson I
J Immunol; 1994 Dec; 153(12):5607-17. PubMed ID: 7989760
[TBL] [Abstract][Full Text] [Related]
20. The X-linked immunodeficiency defect in the mouse is corrected by expression of human Bruton's tyrosine kinase from a yeast artificial chromosome transgene.
Maas A; Dingjan GM; Savelkoul HF; Kinnon C; Grosveld F; Hendriks RW
Eur J Immunol; 1997 Sep; 27(9):2180-7. PubMed ID: 9341757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
